OR51E1 and prostate cancer: Massberg et al. obtained RNA-Seq data by high-throughput sequencing, and verified the abnormal expression of PSGR2 in prostate cancer tissues by RT-PCR, which was the highest in benign prostate tissues and almost undetectable in prostate cancer tissues, all lymph nodes and distant metastatic specimens.